🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

135 notícias encontradas para "trial"
Improving growth outcomes for children living with dwarfism
New findings from a trial conducted at Children's Hospital Colorado (Children's Colorado) and University of Colorado (CU) Anschutz School of Medicine demonstrate significantly increased growth rates in children with achondroplasia, the most common form of dwarfism. These results
When back pain won't quit: A large clinical trial points to the power of self-management
When back pain won't quit: A large clinical trial points to the power of self-management
Almost everyone will deal with back pain at some point in their lives. Most recover quickly—but for about 20% of people, acute pain becomes a chronic condition that interferes with daily life and keeps them out of the workforce.
Investigators report promising results from Phase II trial of targeted therapy for rare bi
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy—including a near doubling of p
Could creatine help depression? What five clinical trials show so far
Could creatine help depression? What five clinical trials show so far
Could the same supplement many people take to build muscle also help treat depression? O recorte ajuda a contextualizar a pauta dentro de Fitness.
Common mucus-clearing treatments don't help ICU patients breathe easier and may cause harm
Common mucus-clearing treatments don't help ICU patients breathe easier and may cause harm
For patients struggling to breathe because of acute respiratory failure, clearing mucus from the airways is a routine part of treatment. Mucoactive agents are widely used for this purpose. But after years of clinical use, one question remains: Do mucoactive agents actually help?
'Polypill' for heart failure cuts hospitalizations and ER visits by 60% in trial
A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more effective for patients than taking the drugs separately, a randomized clinical trial led by UT Southwestern Medical Center researchers showed. The findings, publis
Trial of potential Ebola treatments begins in DR Congo: WHO
The trial of two potential treatments for the Bundibugyo species of Ebola behind the deadly outbreak in the DR Congo began in the country Thursday, the World Health Organization said.
AI tool improves prediction of who will respond to cancer immunotherapy drugs
Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a k
Foto: Towfiqu barbhuiya / Pexels
Biomarker-guided care to improve antidepressant response rates and reduce trial-and-error
For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey. Patients often spend months trying different medications, enduring side effects and persistent symptoms while waiting to discover whether a prescription will
Brain tumor vaccine links mutation targeting to eight-year survival gains
A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions
Modest sleep loss linked to weight gain in adults with high cardiometabolic risk
A pooled analysis of two randomized trials found that decreasing sleep by just 1.5 hours each night was associated with increases in body weight, waist circumference and sedentary time in adults with elevated cardiometabolic risk.
Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NET
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy